Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease.
Phase II
· Site: 718 (USA) (Dr. Nolan)
· consented 2013-07-07
Adverse events
4
Serious AEs
0
Open data queries
0
Luna dropout signal
–
Adverse events
moderate
assessed
2026-08-18
Moderate AGITATION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-07-18 (study day 12.0); relationship: POSSIBLE
moderate
assessed
2026-08-18
Moderate INFLAMMATION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-07-30 (study day 24.0); relationship: REMOTE
severe
assessed
2026-08-18
Severe SYNCOPE — outcome: RECOVERED/RESOLVED; onset 2013-07-16 (study day 10.0); relationship: POSSIBLE; serious criteria: hospitalization
severe
assessed
2026-08-18
Severe SYNCOPE — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-07-30 (study day 24.0); relationship: POSSIBLE; serious criteria: hospitalization
Data queries
No data queries.
☾ Luna engagement
This participant doesn't use Luna.